# Efficacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.

> **NCT03513250** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 92 (actual)

## Conditions studied

- Catheter Related Bladder Discomfort

## Interventions

- **DRUG:** hyoscine-n-butylbromide
- **DRUG:** control group

## Key facts

- **NCT ID:** NCT03513250
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-30
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-15
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513250, "Efficacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03513250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*